NASDAQ: OPHI
Collplant Biotechnologies Ltd Stock

$3.28-0.37 (-10.14%)
Updated Nov 16, 2026
OPHI Price
$3.28
Fair Value Price
N/A
Market Cap
$4.74M
52 Week Low
$2.64
52 Week High
$22.50
P/E
-0.35x
P/B
1.61x
P/S
15.83x
PEG
N/A
Dividend Yield
N/A
Revenue
$318.00k
Earnings
-$12.51M
Gross Margin
-321.7%
Operating Margin
-3,932.08%
Profit Margin
-3,934.9%
Debt to Equity
1.44
Operating Cash Flow
-$11M
Beta
0.57
Next Earnings
Nov 25, 2026
Ex-Dividend
N/A
Next Dividend
N/A

OPHI Overview

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine OPHI's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -6.47% per year. Learn More

Zen Rating Component Grades

F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
OPHI
Ranked
#269 of 450

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important OPHI news, forecast changes, insider trades & much more!

OPHI News

Overview

Due Diligence Score

–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OPHI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OPHI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OPHI is good value based on its book value relative to its share price (1.61x), compared to the US Biotechnology industry average (5.03x)
P/B vs Industry Valuation
OPHI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OPHI due diligence checks available for Premium users.

Valuation

OPHI price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.35x
Industry
18.86x
Market
39.84x

OPHI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.61x
Industry
5.03x
OPHI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

OPHI's financial health

Profit margin

Revenue
$108.0k
Net Income
-$2.7M
Profit Margin
-2,524.1%
OPHI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OPHI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$7.2M
Liabilities
$4.3M
Debt to equity
1.44
OPHI's short-term assets ($3.90M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OPHI's short-term assets ($3.90M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OPHI's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
OPHI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.3M
Investing
$14.0k
Financing
$620.0k
OPHI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OPHI vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
OPHID$4.74M-10.14%-0.35x1.61x
SKYE–$4.71M-2.29%-0.14x3.46x
PCSA–$4.81M-7.53%-0.03x-0.03x
PULM–$4.86M+3.10%-1.21x1.90x
ICUD$4.54M+1.91%-0.32x9.68x

Collplant Biotechnologies Stock FAQ

What is Collplant Biotechnologies's quote symbol?

(NASDAQ: OPHI) Collplant Biotechnologies trades on the NASDAQ under the ticker symbol OPHI. Collplant Biotechnologies stock quotes can also be displayed as NASDAQ: OPHI.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.

What is the 52 week high and low for Collplant Biotechnologies (NASDAQ: OPHI)?

(NASDAQ: OPHI) Collplant Biotechnologies's 52-week high was $22.50, and its 52-week low was $2.64. It is currently -85.42% from its 52-week high and 24.24% from its 52-week low.

How much is Collplant Biotechnologies stock worth today?

(NASDAQ: OPHI) Collplant Biotechnologies currently has 1,444,350 outstanding shares. With Collplant Biotechnologies stock trading at $3.28 per share, the total value of Collplant Biotechnologies stock (market capitalization) is $4.74M.

Collplant Biotechnologies stock was originally listed at a price of $89.50 in Jan 31, 2018. If you had invested in Collplant Biotechnologies stock at $89.50, your return over the last 8 years would have been -96.34%, for an annualized return of -33.85% (not including any dividends or dividend reinvestments).

How much is Collplant Biotechnologies's stock price per share?

(NASDAQ: OPHI) Collplant Biotechnologies stock price per share is $3.28 today (as of Nov 16, 2026).

What is Collplant Biotechnologies's Market Cap?

(NASDAQ: OPHI) Collplant Biotechnologies's market cap is $4.74M, as of Nov 17, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Collplant Biotechnologies's market cap is calculated by multiplying OPHI's current stock price of $3.28 by OPHI's total outstanding shares of 1,444,350.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.